Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02649153Phase 3Completed
Phase 3, randomised, open-label trial (3 arms), sponsored by Guangxi Medical University. Primary endpoint: Time to first peristalsis at 3 days. Started Jan 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02649153.